Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
BIG DATA ANALYTICS IN PHARMACOVIGILANCE - A GLOBAL TREND
1
Zitationen
5
Autoren
2021
Jahr
Abstract
Big data analysis has enhanced its demand nowadays in various sectors of health-care including pharmacovigilance. The exact definition of big data is not known to many people though it is routinely used by them. Big data refer to immense and voluminous computerized medical information which are obtained from electronic health records, administrative data, registries related to disease, drug monitoring, etc. This data are usually collected from doctors and pharmacists in a health-care facility. Analysis of big data in pharmacovigilance is useful for early raising of safety alerts, line listing them for signal detection of drugs and vaccines, and also for their validation. The present paper is intended to discuss big data analytics in pharmacovigilance focusing on global prospect and domestic country-India.
Ähnliche Arbeiten
A method for estimating the probability of adverse drug reactions
1981 · 11.455 Zit.
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 · 4.798 Zit.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
2004 · 3.197 Zit.
Adverse drug reactions: definitions, diagnosis, and management
2000 · 2.932 Zit.
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group
1995 · 2.509 Zit.